Contraception, Sterilisation, and Abortion Act, 112
Contraception, Sterilisation, and Abortion Act, 112; 1977.
(1977)
3
25844511610
National Certificate of Educational Achievement: Internal assessment resource reference number: Health/1/5 - B version 3 'A ssexuality issues magazine'
Te Kete Ipurangi. Ministry of Education
Te Kete Ipurangi. National Certificate of Educational Achievement: Internal assessment resource reference number: Health/1/5 - B version 3 'A sexuality issues magazine'. Ministry of Education; 2002.
(2002)
4
0036752505
Termination of pregnancy following panic-stopping of oral contraceptives
Goodyear-Smith F, Arroll B. Termination of pregnancy following panic-stopping of oral contraceptives. Contraception 2002;66:163-7.
Data on prescription numbers and ex-manufacturer cost of 2nd and 3rd generation oral contraceptives for each June financial year since 1993
PHARMAC. Wellington: PHARMAC
PHARMAC. Data on prescription numbers and ex-manufacturer cost of 2nd and 3rd generation oral contraceptives for each June financial year since 1993. Wellington: PHARMAC; 2002.
(2002)
6
0029671042
Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
Transnational Research Group on Oral Contraceptives and the Health of Young Women
Spitzer WO, Lewis MA, Heinemann LA, et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996;312:83-8.
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, et al. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995;346:1593-6.
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
World Health Organization Collaborative Study of Cardiovascular Disease & Steroid Hormone Contraception
World Health Organization Collaborative Study of Cardiovascular Disease & Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995;346:1582-8.
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
Jick H, Jick SS, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346:1589-93.
Barriers to use of oral contraceptives in ethnic Chinese women presenting for abortion
Wiebe ER, Sent L, Fong S, Chan J. Barriers to use of oral contraceptives in ethnic Chinese women presenting for abortion. Contraception 2002;65:159-63.